20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Shares of Iridex (NASDAQ:IRIX) decreased 0.4% in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 90.91% year over year to ($0.01), which beat the estimate of ($0.10).
Revenue of $12,304,000 higher by 4.61% year over year, which beat the estimate of $12,260,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Iridex hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Mar 22, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/raqtikd9
Technicals
52-week high: $8.28
52-week low: $1.22
Price action over last quarter: Up 276.41%
Company Overview
IRIDEX Corp is involved in the business of developing, manufacturing and marketing laser-based medical systems, delivery devices and consumable instrumentation for ophthalmology. Its products include lasers, laser delivery devices, glaucoma devices, retinal surgical instruments, veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment that is ophthalmology. The geographical segments of the company include the United States, Europe, the Americas, excluding the U.S and Asia/Pacific.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!